GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2024 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.200-4.350 for the period, compared to the consensus EPS estimate of 4.300. The company issued revenue guidance of -. GE HealthCare Technologies also updated its FY24 guidance to $4.20-4.35 EPS.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on GEHC. Morgan Stanley raised their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an equal weight rating in a research note on Monday, February 12th. Mizuho lifted their price target on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a buy rating in a research note on Thursday, April 11th. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an outperform rating in a report on Thursday, April 4th. Citigroup upped their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a buy rating in a research note on Wednesday, April 3rd. Finally, HSBC began coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They set a buy rating and a $100.00 target price on the stock. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of Moderate Buy and a consensus price target of $95.09.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded down $11.70 during mid-day trading on Tuesday, hitting $77.24. The stock had a trading volume of 8,601,467 shares, compared to its average volume of 3,369,783. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The company has a 50 day simple moving average of $88.98 and a 200-day simple moving average of $78.75. The stock has a market capitalization of $35.25 billion, a price-to-earnings ratio of 26.79, a P/E/G ratio of 3.00 and a beta of 0.95. GE HealthCare Technologies has a 52 week low of $62.35 and a 52 week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the previous year, the company posted $1.31 earnings per share. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, research analysts expect that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.